Dr. R. Moulton-Barrett
2-05
STANDARD PROCEDURE FOR PHYSICIAN”S ASSISTANTS
REGISTERED NURSES PERFORMING BOTOX®
COSMETIC INJECTIONS
_____________________________________________________________________
I.
POLICY
A.
Circumstances under which the PA, RN may perform BOTOX®
COSMETIC injections.
1.
Setting:
a.
Brentwood or Alameda Medical Offices of Dr. Rex MoultonBarrett
2.
Supervision:
a.
The Physician(MD), Physician’s Assistant( PA) or Registered
Nurse(RN) who is trained and qualified will assess the
patient prior to treatment to ensure the patient is a candidate
for BOTOX® COSMETIC. The patient’s Medical History
Questionnaire will be discussed in-depth with patient.
(Questionnaire attached).
b.
The MD, PA or RN will then treat the patient with Bo Tox ( Allergan
),
providing that the patient meets patient criteria, and
Medical History Questionnaire has been completed.
c.
The physician will review the treatment rendered and sign
the chart upon review
3.
Patient Conditions:
a.
Consultation regarding patient’s chief complaint completed.
b.
Ensure patient is a candidate for BOTOX® COSMETIC
treatment by discussing the Medical History Questionnaire
with the patient (please see attached questionnaire).
c.
Caution must be exercised if patient is taking
*aminoglycoside antibiotics, as this may potentate the
effects of BOTOX® COSMETIC.
d.
Patient is aware of potential adverse events following
injection of BOTOX® COSMETIC . These are headache,
respiratory infection, flu syndrome, blepharoptosis and
nausea.
e.
Patient must be at least 18 years of age, or parent/legal
guardian may authorize treatment by filing out medical
questionnaire and signing consent form.
f.
Patient is ≤65 years of age.
g.
Informed consent given and consent form completed.
4.
Contraindications:
a.
Pregnancy.
ADDEND-F-BOTOX-PROCEDURE
STANDARD PROCEDURE FOR REGISTERED NURSES PERFORMING BOTOX®
COSMETIC INJECTIONS
BOTOX® COSMETIC can not be used if there is an infection
at the proposed injection site(s).
5.
Precautions:
a.
General: Epinephrine should be available or other
precautionary methods taken as necessary should an
anaphylactic reaction occur.
*aminoglycoside antibiotics (e.g., streptomycin and gentamicin) are derived
from various species of Streptomyces, which interfere with the function of
bacterial ribosomes.)
b.
II.
PROTOCOL
A.
B.
C.
Definition: The administration of the BOTOX® COSMETIC is indicated
for the temporary improvement in the appearance of moderate to severe
glabellar lines associated with corrugator and/or procerus muscle activity
in adult patients ≤65 years of age.
Assessment:
1.
Subjective: The above patient conditions have been met.
2.
Objective:
The patient present with moderate to severe glabellar
lines as indicated in Definition A. above.
Plan:
1.
Storage: Unopened vials of BOTOX® COSMETIC should be stored
in a refrigerator (2º - 8º C) for up to 24 months. Do not use after
expiration date on the vial. Administer BOTOX® COSMETIC within
4 hours of reconstitution; during this period store in refrigerator.
Order BOTOX® COSMETIC per patient scheduled requirements.
2.
Treatment:
a.
BOTOX® COSMETIC dilution technique: Reconstituted
vacuum-dried BOTOX® COSMETIC with preservative free
0.9% Sodium Chloride.
Diluent
1.0 ml =
2.0 ml =
4.0 ml =
8.0 ml =
b.
c.
d.
e.
BOTOX-PROCEDURE
Resulting dose
10.0 units per 0.1 ml
5.0 units per 0.1 ml
2.5 units per 0.1 ml
1.25 units per 0.1 ml
Prep treatment site with alcohol.
Decrease discomfort and minimize the risk of ecchymosis by
application of cool compress for five minutes.
All muscles must be contracted prior to injection.
Inject accurate medication into the belly of the appropriate
muscle, not to exceed 25 units per muscle.
2
STANDARD PROCEDURE FOR REGISTERED NURSES PERFORMING BOTOX®
COSMETIC INJECTIONS
f.
g.
3.
4.
5.
III.
Apply pressure directly after injection. No rubbing or
massaging of skin after BOTOX® COSMETIC injection.
Post treatment - cleanse site with alcohol.
Patient Education:
a.
Instruct patient not to exercise for at least 8 hours post
treatment.
b.
Patient not to recline for 4 hours.
c.
Instruct patient not to massage treatment sites for 4 days.
d.
Advise patient not to have microdermabration treatment for
7 days after receiving BOTOX® COSMETIC.
e.
Inform patient bruising may occur and last 7-10 days.
f.
Inform patient redness and slight swelling may occur at the
injection site.
g.
Inform patient that a temporary eyelid droop (blepharoptosis)
may occur. Note: Prescription eye medication (drops) may
be ordered by physician to treat blepharoptosis condition.
h.
Patient to notify
should any
concerns or questions arise.
Follow-up:
a.
Patient to return in two weeks for assessment of treatment.
b.
Subsequent treatment scheduled upon re-innervations of
muscles, approximately 2-6 months.
Documentation:
The following information must be recorded in patient’s chart with
each treatment.
a.
Amount of dilution and units injected per muscle.
b.
Muscle treated.
c.
Syringe lot numbers.
d.
Specific areas treated.
e.
Patient response to treatment.
f.
Procure physician review and sign-off on patient charts
within 7 days post procedure.
REQUIREMENTS FOR RN
A.
Education: Graduate of PA, RN program with current California
PA, RN license.
B.
Training:
1.Training by MD specific to product knowledge and proper
technique.
BOTOX-PROCEDURE
3
STANDARD PROCEDURE FOR REGISTERED NURSES PERFORMING BOTOX®
COSMETIC INJECTIONS
2.
3.
4.
5.
6.
a.
b.
BOTOX-PROCEDURE
Formal education from BOTOX® COSMETIC product
representative to increase knowledge, experience and
proficiency in the proper administration of the product.
Experience:
a.
No previous experience necessary.
Initial Evaluation: Successful completion of BOTOX®
COSMETIC education, training and demonstration of
competency to MD.
Physician will review and sign-off all patient charts within 7
days post procedure.
On-going evaluation:
Random MD visits during treatment sessions. MD will
observe at least 3 treatments quarterly.
Annual performance evaluation by Program Manager.
4